Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Study protocol

Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol

Authors: Samarasimha Reddy, Nayana P. Nair, Sidhartha Giri, Venkata Raghava Mohan, Jacqueline E. Tate, Umesh D. Parashar, Mohan D. Gupte, Rashmi Arora, Gagandeep Kang, Indian Intussusception Surveillance Network

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

ROTAVAC, an indigenous rotavirus vaccine, was introduced in the universal immunization program of India in four states in 2016 and expanded to five more states in 2017. The clinical trial on efficacy of ROTAVAC did not detect an increased risk of intussusception, but the trial was not large enough to detect a small risk. This protocol paper describes the establishment and implementation of a surveillance system to monitor the safety of rotavirus vaccine and investigate the potential infectious etiologies of intussusception.

Methods

This is a multi-centric hospital-based active surveillance being conducted at 28 hospitals in nine states of India. Data gathered from surveillance will be used to assess the risk of intussusception after ROTAVAC administration and to determine the infectious etiologies of intussusception. For safety assessment of ROTAVAC vaccine, children aged less than two years with intussusception admitted at the sentinel hospitals are enrolled into surveillance, a case report form completed, and a copy of the vaccination card obtained. The risk of intussusception following rotavirus vaccination will be assessed using a self-controlled case-series design. The investigation for potential infectious etiologies of intussusception is through a matched case-control design. Children enrolled for the safety assessment serve as cases and for each case, an age, gender and location matched control is enrolled within 30 days of case enrollment. Stool specimens are obtained from cases and controls. All forms and specimens are sent to the referral laboratory for data entry, analysis, multiplexed molecular testing, and storage.

Discussion

Anticipated public health benefits of this surveillance include the generation of information useful to national government on safety of vaccine and to make future decisions on vaccine use through risk-benefit analysis. Investigating infectious agents may help to determine the potential infectious etiologies of intussusception.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, Agocs M, Serhan F, et al. Global, regional, and National Estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62:S96–105.CrossRefPubMed Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, Agocs M, Serhan F, et al. Global, regional, and National Estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62:S96–105.CrossRefPubMed
2.
go back to reference John J, Sarkar R, Muliyil J, Bhandari N, Bhan MK, Kang G. Rotavirus gastroenteritis in India, 2011–2013: Revised estimates of disease burden and potential impact of vaccines. Vaccine. 2014;32(Supplement 1):A5–9.CrossRefPubMed John J, Sarkar R, Muliyil J, Bhandari N, Bhan MK, Kang G. Rotavirus gastroenteritis in India, 2011–2013: Revised estimates of disease burden and potential impact of vaccines. Vaccine. 2014;32(Supplement 1):A5–9.CrossRefPubMed
3.
go back to reference WHO. Rotavirus vaccines. WHO position paper – January 2013. Wkly Epidemiol Rec. 2013;88:49–64. WHO. Rotavirus vaccines. WHO position paper – January 2013. Wkly Epidemiol Rec. 2013;88:49–64.
4.
go back to reference Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:2136–43.CrossRefPubMedPubMedCentral Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:2136–43.CrossRefPubMedPubMedCentral
7.
go back to reference Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72.CrossRefPubMed Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72.CrossRefPubMed
8.
go back to reference Advisory Committee on Immunization Practices (ACIP). Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 1999;48:1–20. Advisory Committee on Immunization Practices (ACIP). Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 1999;48:1–20.
9.
go back to reference Diseases C on I. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics. 1998;102:1483–91.CrossRef Diseases C on I. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics. 1998;102:1483–91.CrossRef
10.
go back to reference Centers for Disease Control and Prevention (CDC). Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48:1007. Centers for Disease Control and Prevention (CDC). Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48:1007.
12.
go back to reference Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: the example of rotavirus vaccines. Am J Prev Med. 2015;49:S377–82.CrossRefPubMed Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: the example of rotavirus vaccines. Am J Prev Med. 2015;49:S377–82.CrossRefPubMed
13.
go back to reference Yen C, Healy K, Tate JE, Parashar UD, Bines J, Neuzil K, et al. Rotavirus vaccination and intussusception – science, surveillance, and safety: a review of evidence and recommendations for future research priorities in low and middle income countries. Hum Vaccines Immunother. 2016;12:2580–9.CrossRef Yen C, Healy K, Tate JE, Parashar UD, Bines J, Neuzil K, et al. Rotavirus vaccination and intussusception – science, surveillance, and safety: a review of evidence and recommendations for future research priorities in low and middle income countries. Hum Vaccines Immunother. 2016;12:2580–9.CrossRef
14.
go back to reference Tate JE, Steele AD, Bines JE, Zuber PLF, Parashar UD. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary. Vaccine. 2012;30:A179–84.CrossRefPubMed Tate JE, Steele AD, Bines JE, Zuber PLF, Parashar UD. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary. Vaccine. 2012;30:A179–84.CrossRefPubMed
15.
go back to reference Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014;370:503–12.CrossRefPubMed Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014;370:503–12.CrossRefPubMed
16.
go back to reference Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370:513–9.CrossRefPubMed Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370:513–9.CrossRefPubMed
18.
go back to reference Montgomery EA, Popek EJ. Intussusception, adenovirus, and children: a brief reaffirmation. Hum Pathol. 1994;25:169–74.CrossRefPubMed Montgomery EA, Popek EJ. Intussusception, adenovirus, and children: a brief reaffirmation. Hum Pathol. 1994;25:169–74.CrossRefPubMed
19.
go back to reference Porter HJ, Padfield CJ, Peres LC, Hirschowitz L, Berry PJ. Adenovirus and intranuclear inclusions in appendices in intussusception. J Clin Pathol. 1993;46:154–8.CrossRefPubMedPubMedCentral Porter HJ, Padfield CJ, Peres LC, Hirschowitz L, Berry PJ. Adenovirus and intranuclear inclusions in appendices in intussusception. J Clin Pathol. 1993;46:154–8.CrossRefPubMedPubMedCentral
20.
go back to reference Okimoto S, Hyodo S, Yamamoto M, Nakamura K, Kobayashi M. Association of viral isolates from stool samples with intussusception in children. Int J Infect Dis. 2011;15:e641–5.CrossRefPubMed Okimoto S, Hyodo S, Yamamoto M, Nakamura K, Kobayashi M. Association of viral isolates from stool samples with intussusception in children. Int J Infect Dis. 2011;15:e641–5.CrossRefPubMed
21.
go back to reference Bines JE, Liem NT, Justice FA, Son TN, Kirkwood CD, de Campo M, et al. Risk factors for intussusception in infants in Vietnam and Australia: Adenovirus implicated, but not rotavirus. J Pediatr. 2006;149:452–60. e1CrossRefPubMed Bines JE, Liem NT, Justice FA, Son TN, Kirkwood CD, de Campo M, et al. Risk factors for intussusception in infants in Vietnam and Australia: Adenovirus implicated, but not rotavirus. J Pediatr. 2006;149:452–60. e1CrossRefPubMed
22.
go back to reference Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.CrossRefPubMed Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.CrossRefPubMed
23.
go back to reference Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22:569–74.CrossRefPubMed Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22:569–74.CrossRefPubMed
24.
go back to reference Liu J, Gratz J, Amour C, Kibiki G, Becker S, Janaki L, et al. A laboratory-developed TaqMan Array card for simultaneous detection of 19 Enteropathogens. J Clin Microbiol. 2013;51:472–80.CrossRefPubMedPubMedCentral Liu J, Gratz J, Amour C, Kibiki G, Becker S, Janaki L, et al. A laboratory-developed TaqMan Array card for simultaneous detection of 19 Enteropathogens. J Clin Microbiol. 2013;51:472–80.CrossRefPubMedPubMedCentral
25.
go back to reference Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics. 2009;10:3–16.CrossRefPubMed Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics. 2009;10:3–16.CrossRefPubMed
26.
go back to reference Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Stat Methods Med Res. 2009;18:7–26.CrossRefPubMed Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Stat Methods Med Res. 2009;18:7–26.CrossRefPubMed
27.
go back to reference Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904–14.CrossRefPubMed Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904–14.CrossRefPubMed
28.
go back to reference Blackwelder WC, Biswas K, Wu Y, Kotloff KL, Farag TH, Nasrin D, et al. Statistical methods in the global enteric multicenter study (GEMS). Clin Infect Dis. 2012;55:S246–53.CrossRefPubMedPubMedCentral Blackwelder WC, Biswas K, Wu Y, Kotloff KL, Farag TH, Nasrin D, et al. Statistical methods in the global enteric multicenter study (GEMS). Clin Infect Dis. 2012;55:S246–53.CrossRefPubMedPubMedCentral
30.
go back to reference Meeting on Future Directions for Rotavirus Vaccine Research in Developing Countries (2000: Geneva, Switzerland & WHO Department of Vaccines and Biologicals. Report of the meeting on future directions for rotavirus vaccine research in developing countries, Geneva, 9–11 February 2000. Available from: http://apps.who.int/iris/handle/10665/66497 [cited 2018 Jun 17]. Meeting on Future Directions for Rotavirus Vaccine Research in Developing Countries (2000: Geneva, Switzerland & WHO Department of Vaccines and Biologicals. Report of the meeting on future directions for rotavirus vaccine research in developing countries, Geneva, 9–11 February 2000. Available from: http://​apps.​who.​int/​iris/​handle/​10665/​66497 [cited 2018 Jun 17].
Metadata
Title
Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol
Authors
Samarasimha Reddy
Nayana P. Nair
Sidhartha Giri
Venkata Raghava Mohan
Jacqueline E. Tate
Umesh D. Parashar
Mohan D. Gupte
Rashmi Arora
Gagandeep Kang
Indian Intussusception Surveillance Network
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5809-7

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue